CanAm Scientific Announces the Approval of the STANDARD Q COVID-19 RAPID ANTIGEN Test Kit

These Test Kits are the most competitively priced rapid point-of-care antigen test kits in the Canadian market.

CanAm Scientific’s CEO Anthony Travonti says, “These rapid test kits identify SARS-CoV-2 in 15 minutes, which allows for informed decisions by healthcare professionals in diverse locations or in settings with limited resources or limited access to laboratory testing facilities. This permits fast decisions and quick isolation, thereby reducing the risk of further viral spread.”

With a high end sensitivity of 99.04% and specificity of 99.99% based on most recent data, it is an instrument-free complete test kit that provides convenience and reliability in a timely manner.

Mr. Travonti says, “This rapid antigen test kit is a fast chromatographic immunoassay devised to detect SARS-CoV-2 by means of the viral nucleocapsid protein present in the virus within the human nasopharynx. It’s optimal to use it within the first 5 - 7 days of the onset of clinical symptoms. This test was developed by SD Biosensor in South Korea a year ago and has been successfully used there and in many other countries to help detect and combat Covid-19.”

The STANDARD Q COVID-19 Ag Test Kit was the first rapid antigen test kit to be approved for emergency use by the World Health Organization. It has full Korea MFDS approval and TGA approval in Australia, and carries the CE mark. It is intended for use by healthcare professionals to aid and assist in the early detection of SARS-CoV-2 infections.

• Easy to use
• Test time: 15 - 30 minutes
• Specimen: Nasopharyngeal swab
• Shelf life: 24 months
• Storage temperature: 2-30ºC/36-86ºF
• Pack size: 25T/kit; 30 kits/carton
• All necessary reagents provided & no special equipment required

SD Biosensor in partnership with CanAm Scientific has set aside millions of these Test Kits for use in Canada to ensure the health and safety of Canadians.

About antigen testing:

Antigen tests identify specific proteins that are functional components of a pathogen, providing a qualitative positive or negative result as to the presence of the pathogen in a patient’s sample. During an acute infection, when the viral load is high, these specific proteins bind to antibodies located on the test strip and display a positive result, proving active infection. Negative results must still be considered in the context of other pertinent patient information like clinical symptoms, travel history and COVID-19 exposure.

CanAm Scientific is a global leader in the technology supply industry, committed to serving the evolving needs of the international community, and provides support to help minimize the impact of COVID-19. They offer a diverse portfolio of diagnostics and personal protective equipment (PPE) designed to keep people safe and to help stop the spread of the SARS-CoV-2 virus. Led by an experienced management team and established over 28 years ago, CanAm Scientific has consistently focused on providing innovative products, superior service, and competitive pricing.

They are currently working with governments, public health authorities, institutions, laboratories, and healthcare providers to ensure that people and communities are provided with the tests, treatments, and protection they need in order to remain healthy.

In North America, Europe and the Middle East, in association with Aqualution UK, CanAm Scientific supplies its domestic and international customers with technology that conforms to clearly established requirements and performance standards to guarantee long-term user satisfaction. Some global clients include McDonald’s, Siemens, Toyota, BUPA, the NHS UK, the Dubai Health Authority, and Samsung.

CanAm Scientific offers the most advanced infection and pathogen fighting technologies, without harmful effects on the environment, and is revolutionizing the way the world builds, cleans, and protects.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210311005086/en/